Vol 55, No 4 (2024)
Clinical vignette
Published online: 2024-08-29
Toxic epidermal necrolysis after allogeneic hematopoietic stem cell transplantation for refractory Hodgkin’s lymphoma.
1
, 2, 2, 1
, 2, 2, 1
DOI: 10.5603/ahp.100540
Acta Haematol Pol 2024;55(4):221-223.
Abstract
Not available
Keywords: toxic epidermal necrolysisallogenic hematopoietic stem cell transplantationHodgkin's lymphoma
References
- Ansell SM. Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2022; 97(11): 1478–1488.
- Dambricourt V, Bassompierre A, Calve CLe, et al. High frequency of cutaneous eruptions within the first year after allogeneic hematopoietic stem cell transplantation. JEADV Clinical Practice. 2023; 2(3): 456–464.
- Hung YT, Chen YW, Huang Y, et al. Acute graft-versus-host disease presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study. J Am Acad Dermatol. 2023; 88(4): 792–801.
- Srinagesh HK, Özbek U, Kapoor U, et al. The MAGIC algorithm probability is a validated response biomarker of treatment of acute graft-versus-host disease. Blood Adv. 2019; 3(23): 4034–4042.
- Labib A, Milroy C. Toxic Epidermal Necrolysis. https://www.statpearls.com/point-of-care/135196 (15.08.2024).
- Watanabe Y, Yamaguchi Y, Takamura N, et al. Toxic epidermal necrolysis accompanied by several immune-related adverse events developed after discontinuation of nivolumab. Eur J Cancer. 2020; 131: 1–4.
- Griffin LL, Cove-Smith L, Alachkar H, et al. Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma. JAAD Case Rep. 2018; 4(3): 229–231.
- Macedo FI, Faris J, Lum LG, et al. Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management. J Burn Care Res. 2014; 35(6): e431–e435.
- Jeanmonod P, Hubbuch M, Grünhage F, et al. Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation. Transpl Infect Dis. 2012; 14(4): 422–426.
- Bashiri Aliabadi S, Haghani Dogahe Z, Feizkhah A, et al. Management of toxic epidermal necrolysis using early combination therapy of intravenous immunoglobulin and amniotic membrane grafting: a case report. J Burn Care Res. 2023; 44(2): 467–470.
- McCurdy SR, Kasamon YL, Kanakry CG, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide. Haematologica. 2017; 102(2): 391–400.